Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam pharmacokinetics in elderly ICU patients
NL-OMON45744Withdrawn
- Sponsor
- ICU Medical
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of midazolam, sponsored by ICU Medical. Primary endpoint: Pharmacokinetic profile of midazolam. Planned start Dec 2019; status: withdrawn.
02
Drugs
midazolam
Beyond the preview
Go deeper on NL-OMON45744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45744.